FindTrial
Sign In

The effect of saffron in patients with polycystic ovarian syndrome

The effect of saffron on serum levels of IL-6, TNF-a, insulin and lipid profiles in patients with polycystic ovarian syndrome

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200219046558N1
Enrollment
50
Registered
2020-04-13
Start date
2020-02-20
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovarian syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention group: 25 patient are in this group, and 12 weeks of saffron capsules will be given orally once daily at a dose of 30 mg. The capsules will be manufactured by Kimia Daru.

Sponsors

Ardabil University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 40 Years

Inclusion criteria

Inclusion criteria: Gynecologist diagnoses polycystic ovary syndrome No other disease Age 15 to 40 years

Exclusion criteria

Exclusion criteria: Having a underlying like diabetes or cancers taking medication Addiction to any drug

Design outcomes

Primary

MeasureTime frame
IL-6 serum level. Timepoint: Before treatment and 12 weeks after treatment. Method of measurement: Serum level test answer.;Insulin serum level. Timepoint: Before treatment and 12 weeks after treatment. Method of measurement: Serum level test answer.;TNF-a serum level. Timepoint: Before treatment and 12 weeks after treatment. Method of measurement: Serum level test answer.;Lipid profile serum level. Timepoint: Before treatment and 12 weeks after treatment. Method of measurement: Serum level test answer.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGiti Rahimi

Ardabil University of Medical Sciences

meisamfooladi@gmail.com+98 45 3323 0739

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026